Events & Presentations
Upcoming Events
| Date | Event Details | Remind Me |
|---|---|---|
|
Nov 30, 2021
|
Piper Sandler 33rd Annual Healthcare Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
|
|
|
Dec 2, 2021 1:00 PM EST
|
4th Annual Evercore ISI HealthCONx Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
|
|
|
Dec 3, 2021
|
18th Global Cardiovascular Clinical Trialists Forum
James Hamilton, MD, MBA, Arrowhead’s senior vice president of discovery & translational medicine, will participate in a panel discussion titled, “Developments in Hypertriglyceridemia Trials”
|
Archived Events
| Date | Event Details |
|---|---|
|
Oct 4, 2019 10:05 AM EDT
|
2019 Cantor Global Healthcare Conference
New York, NY
Vince Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in a fireside chat presentation with Elemer Piros, Ph.D., Cantor Fitzgerald biotechnology equity research analyst
|
|
Sep 20, 2019 4:15 PM CEST
|
Molecular Therapies for Liver Disease in Alpha-1 Antitrypsin Deficiency
View Presentation 10.5 MB
Naples, Italy
|
|
Sep 16, 2019 11:00 AM +04
|
Global Summit On Cardiology & Heart Diseases
View Presentation 5.6 MB
Dubai, UAE
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver a keynote presentation titled, “Treating hypertriglyceridemic states with RNA interference – emergence of an exciting new modality to treat cardiovascular diseases”
|
|
Sep 16, 2019
|
Developing Alpha-1 Antitrypsin Therapeutics; FDA Public Workshop
View Presentation 7.1 MB
Bethesda, MD
|
|
Sep 14, 2019
|
Alpha-1 UK Support Group Event 2019
View Presentation 5 MB
Daventry, Northamptonshire, UK
|
|
Sep 5, 2019
|
Citi’s 14th Annual Biotech Conference
Boston, MA
|
|
Sep 4, 2019 9:40 AM EDT
|
Baird's 2019 Global Healthcare Conference
New York, NY
|
|
Aug 12, 2019
|
BTIG Biotechnology Conference 2019
New York, NY
|
|
Aug 5, 2019 4:30 PM EDT
|
Arrowhead Pharmaceuticals 2019 Third Quarter Results
Prepared Remarks 181.4 KB
|
|
Jul 17, 2019
|
Roth RNA Revolution Conference
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, and Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in panel discussions.
|